SARS-Cov-2

SEATTLE — COVID-19, caused by SARS-CoV-2 infection, is linked to a wide range of conditions that affect neurological processes, according to an expert at the 2022 American Academy of Neurology annual meeting.

Stress, burnout, anxiety, depression and fear of COVID-19 were reported among general practitioners throughout the pandemic, a global study published in the British Journal of General Practice found.

SEATTLE — Full recovery and functional independence is possible in patients who experience a disorder of consciousness after severe COVID-19 infection, according to a presenter at the 2022 American Academy of Neurology annual meeting.

The Th2 cytokine IL-13 appeared to play a significant role in protecting people with allergic asthma against the damaging effects of SARS-CoV-2 infection, according to a study published in Proceedings of the National Academy of Sciences.

SEATTLE — People with persistent cognitive symptoms after mild COVID-19 infection had elevated cerebrospinal fluid inflammatory markers, according to a presentation at the 2022 American Academy of Neurology annual meeting.

Older patients taking psychotropic medication were about three times more likely to develop dementia following a SARS-CoV-2 infection, researchers reported in Frontiers in Medicine.

As of late February, just 64.5% of Americans were fully vaccinated against COVID-19, and less than half of eligible people had received a recommended booster dose.

Last month, The New York Times reported that the CDC has withheld some of the data it has collected on COVID-19 boosters and hospitalizations.

Incidence rates for Bell’s palsy, encephalomyelitis and Guillain- Barré syndrome were higher in unvaccinated people with SARS-CoV-2 infection compared with those vaccinated against COVID-19, researchers reported in BMJ.

CDC data show that the omicron BA.2 subvariant of SARS-CoV-2 accounted for approximately 35% of COVID-19 cases in the United States during the week ending March 19, up from around 22% the week before.